louisbrulenaudet/clinical-trials huggingface dataset:
Clinical trial NCT05553080: Significance of Immunohistochemical Expression of Fascin-1 in Colorectal Carcinoma
Official title: Significance of Immunohistochemical Expression of Fascin-1 in Colorectal Carcinoma
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Cancer of Colon
Keywords: Cancer Colon
Fascin-1
Actin assembly
Lead sponsor: Sohag University
Sponsor class: OTHER
First posted: 2022-09-23
Enrollment: 60
Sex: ALL
Minimum age (years): 30
Maximum age (years): 90
Standard ages: ADULT
OLDER_ADULT
Observational model: CASE_ONLY
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients had colorectal carcinoma who underwent radical colectomy operations in Sohag University Hospital, Sohag, Egypt.

Brief summary: Colorectal carcinoma is a major health problem. As a malignant tumor, the malignant potential of colorectal carcinoma is based mainly on its ability to metastasis to different sites. Fascin-1 is an actin binding protein which is involved in reconstruction of intracellular actin network, the latter enforces the neoplastic cell to invade surrounding structures.

Detailed description: colorectal carcinoma is an aggressive malignant tumor. It has high incidence of cancer-related morbidity and mortality. the malignant potential of a given neoplasm is based mainly on its ability to invade the surrounding vasculature and reach to distant sites, the latter is called metastasis. in order to metastasize to distant sites, the neoplastic cells must re-arrange the intracellular actin filaments into well formed intracellular assembly which enable the neoplastic cells to reach to distant sites. Fascin-1 is an actin binding protein, it is involved in reconstruction of actin assembly. fortunately, Fascin-1 could be blocked by newly developed medications, blocking of Fascin-1 may limit the metastasis of colorectal carcinoma. in current study the investigators detect Fascin-1 in colorectal carcinoma by immunohistochemical approach, then they correlated different levels of Fascin-1 expression to tumor clinical and pathological criteria as patients' ages, sexes, tumor stages, nodal metastasis, vascular and per-ineural invasions.

Eligibility criteria: Inclusion Criteria:

* All cases of colorectal carcinoma.

Exclusion Criteria:

* cases diagnosed on basis of lower endoscopic biopsies or local resections without radical colectomy.
* Patients with preopoerative history of chemo or radiotherapy.
* Patients with poor clinical data.

Primary outcomes:
measure: Evaluation of immunohistochemical staining of colorectal carcinoma by Fascin-1
timeFrame: September , 2022
Secondary outcomes:
Other outcomes:
Locations:
city: Sohag
country: Egypt
facility: Maisa Hashem Mohammed
city: Sohag
country: Egypt
facility: Sohag faculty of medicine
Study officials:
References:
Clinical trial NCT04604080: Post-COVID-19 Epidemic Depression Assessment in Adults in South Punjab Pakistan
Official title: Post-COVID-19 Epidemic Depression Assessment in Adults in South Punjab Pakistan
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Depression, Anxiety
Keywords: Depression
Anxiety
Epidemiology
Lead sponsor: Islamia University of Bahawalpur
Sponsor class: OTHER
First posted: 2020-10-27
Enrollment: 390
Sex: ALL
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: OTHER
Time perspective: RETROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: Residents/ Visitors of the south punjab will be the study population of this study

Brief summary: To assess the depression in adults especially in post COVID-19 duration in the rural and urban settings.

Detailed description: This study is designed to assess the prevalence of depression after the general and smart lockdown in various areas. This study includes both genders of any age.

Eligibility criteria: Inclusion Criteria:Any individual who can respond to the given questionnaire, with or without any ailment will be included in this study -

Exclusion Criteria:

Unconcious and non-cooperative individuals

-

Primary outcomes:
measure: Prevalence estimation of depression in adults
timeFrame: study will be completed in 15 days maximum
Secondary outcomes:
Other outcomes:
Locations:
city: Bahāwalpur
country: Pakistan
facility: The Islamia University of Bahawalpur
state: Punjab
city: Faisalabad
country: Pakistan
facility: GC University Faisalabad
state: Punjab
city: Lahore
country: Pakistan
facility: University of Veterinary and Animal Sciences, Lahore
state: Punjab
city: Multan
country: Pakistan
facility: Bahauddin Zakriya University Multan
state: Punjab
city: Islamabad
country: Pakistan
facility: Quaid-i-Azam University Islamabad
Study officials:
affiliation: The Islamia University of Bahawalpur
name: Jafir Shirazi, PhD
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT03508180: Benefit Evaluation of Foot Reflexology in Oncology
Official title: Randomized Study Assessing the Benefits of Foot Reflexology in Patients With Gastrointestinal or Thoracic Cancer With Chemotherapy
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Lung Cancer and Cancer of Digestive System
Keywords: Supportive care
cancer
foot reflexology
nausea
vomiting
Lead sponsor: Hospices Civils de Lyon
Sponsor class: OTHER
First posted: 2018-04-25
Enrollment: 80
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: SUPPORTIVE_CARE

Brief summary: Chemotherapy with platinum salts is very emetic. The aim of this study is to evaluate the benefits of foot reflexology in nausea and vomiting induced by platinum salts-based chemotherapy in patients with thoracic or digestive tumors.


Eligibility criteria: Inclusion Criteria:

* Patient with a thoracic or digestive cancer with indication of management with platinum salts-based chemotherapy
* Good performance status of (ECOG 0-2)
* More than 18 years old
* Ability to complete the questionnaires (comprehension oral and written French language) and to carry out the required exercises.
* Patient affiliated to Social Security or equivalent
* Informed consent signed

Exclusion Criteria:

* Phlebitis
* Cellar syndrome
* Weight loss\> 5% in 3 months
* Uncontrolled pain
* Patients under morphine and derivatives
* Brain metastases
* Patient benefiting from foot reflexology outside the study
* Patient under guardianship or curatorship or deprived of his rights

Primary outcomes:
measure: Evaluation of nausea and vomiting
timeFrame: 6 hours
Secondary outcomes:
measure: Nausea and vomiting between each chemotherapy
timeFrame: Day 0, between day 14 and day 21, between day 28 and day 42, between day 42 and day 63.
measure: Quality of life
timeFrame: Between day 0 and day 78
measure: Anxiety
timeFrame: Between day 0 and day 78
measure: Body image
timeFrame: Day 0
Other outcomes:
Locations:
city: Pierre-Bénite
country: France
facility: Centre Hospitalier Lyon Sud
Study officials:
affiliation: Hospices Civils de Lyon
name: Pierre-Jean SOUQUET, MD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Murat-Ringot A, Souquet PJ, Subtil F, Boutitie F, Preau M, Piriou V. The Effect of Foot Reflexology on Chemotherapy-Induced Nausea and Vomiting in Patients With Digestive or Lung Cancer: Randomized Controlled Trial. JMIR Cancer. 2021 Nov 5;7(4):e25648. doi: 10.2196/25648.
citation: Murat-Ringot A, Souquet PJ, Chauvenet M, Rentler C, Subtil F, Schott AM, Preau M, Piriou V. The Effects of Foot Reflexology on Chemotherapy-Induced Nausea and Vomiting in Patients with Digestive System or Lung Cancer: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2020 Jul 14;9(7):e17232. doi: 10.2196/17232.
Clinical trial NCT00155480: Establish Finite Element Mesh of the Numerical Models of the Thoracic Aorta
Official title: Establish Finite Element Mesh of the Numerical Models of the Thoracic Aorta
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Heart Diseases
Keywords: thoracic aorta
finite element mesh
Lead sponsor: National Taiwan University Hospital
Sponsor class: OTHER
First posted: 2005-09-12
Enrollment: 80
Sex: ALL
Minimum age (years): 1
Maximum age (years): 80
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: SINGLE_GROUP
Primary purpose: DIAGNOSTIC

Brief summary: This study will be using finite element meshes and averaged algorithms to create the numerical thoracic aorta at different ages.

Detailed description: This study will be using finite element meshes and averaged algorithms to create the numerical thoracic aorta at different ages.

Eligibility criteria: Inclusion Criteria:

* Normal thoracic aorta

Primary outcomes:
measure: diagnostic accuracy
Secondary outcomes:
measure: sensitivity
measure: specificity
Other outcomes:
Locations:
city: Taipei
country: Taiwan
facility: Dept. of Medical Imaging, NTaiwanUH
Study officials:
affiliation: Dept. Medical Imaging, NTaiwanUH
name: Shyh-Jye Chen, MD, PhD
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT03041480: Serum Lipid Levels and Lp-PLA2 in Chronic Periodontitis
Official title: The Association Between Periodontal Status, Serum Lipid Levels and Lipoprotein Associated Lipophosphase A2(Lp-PLA2) in Chronic Periodontitis Subjects and Healthy Controls: A Case Control Study
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Chronic Periodontitis (Disorder)
Keywords: chronic periodontitis
lipids
Lp-PLA2
Lead sponsor: Meenakshi Ammal Dental College and Hospital
Sponsor class: OTHER
First posted: 2017-02-02
Enrollment: 75
Sex: ALL
Minimum age (years): 35
Maximum age (years): 64
Standard ages: ADULT
Accepts healthy volunteers: yes
Observational model: CASE_CONTROL
Time perspective: OTHER
Sampling method: NON_PROBABILITY_SAMPLE
Study population: The study population was selected from the Department of Periodontology, Meenakshi Ammal Dental College

Brief summary: To assess the association between periodontal parameters, serum lipid profile and Lp-PLA2 level in systemically healthy Chronic Periodontitis subjects and healthy controls.

Detailed description: Seventy five participants were divided into 3 groups. The groups consisted of GROUP I- generalized severe chronic periodontitis, GROUP II- generalized moderate chronic periodontitis and GROUP III- systemically and periodontally healthy volunteers who served as control. The selected patients were then evaluated for periodontal parameters, lipid profile and Lp-PLA2.

Eligibility criteria: Inclusion Criteria:

Group I:

1. Subjects with age ≥ 35 years.
2. Presence of at least 24 teeth, with Clinical attachment loss (CAL) ≥ 5mm in more than 30% of sites.

Group II:

1. Subjects with age ≥ 35 years.
2. Presence of at least 24 teeth, with Clinical attachment loss (CAL) between 3-4 mm in more than 30% of sites.

Group III:

1. Subjects with age ≥ 35 years.
2. Healthy and intact periodontium

Exclusion Criteria:

1. Presence of any systemic disease or conditions that could affect periodontal tissues.
2. History of periodontal treatment in past 6 months.
3. Smoking and alcoholism
4. Anomalies of blood and immune system
5. Systemic medication or antibiotic treatment for the previous 6 months.
6. Pregnant females.

Primary outcomes:
measure: Estimation of serum Lp-PLA2
timeFrame: 9 months
Secondary outcomes:
measure: Estimation of serum lipid profile
timeFrame: 9 months
Other outcomes:
Locations:
Study officials:
affiliation: Meenakshi Ammal Dental College
name: Bittu Koshy, BDS
role: PRINCIPAL_INVESTIGATOR
References:
citation: Zhou SY, Xiao WM, Ouyang XY. Lipoprotein-associated phospholipase A2 and serum lipid levels in subjects with chronic periodontitis and hyperlipidemia. Chin J Dent Res. 2012;15(1):25-9.
citation: Fentoglu O, Koroglu BK, Kara Y, Dogan B, Yilmaz G, Sutcu R, Ay ZY, Tonguc MO, Orhan H, Tamer MN, Kirzioglu FY. Serum lipoprotein-associated phospholipase A(2) and C-reactive protein levels in association with periodontal disease and hyperlipidemia. J Periodontol. 2011 Mar;82(3):350-9. doi: 10.1902/jop.2010.100417. Epub 2010 Sep 1.
Clinical trial NCT01420562: Pharmacokinetics of Posaconazole in Allogeneic Transplant Patients With Mucositis
Official title: Pharmacokinetics of Posaconazole in Allogeneic Transplant Patients With Mucositis
Study type: OBSERVATIONAL
Overall status: RECRUITING
Conditions: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Keywords: allogeneic HSCT
posaconazole
prophylaxis
mucositis
pharmacokinetics
Lead sponsor: Universitaire Ziekenhuizen KU Leuven
Sponsor class: OTHER
First posted: 2011-08-19
Enrollment: 55
Sex: ALL
Minimum age (years): 18
Maximum age (years): 75
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients on the hematology ward who will receive an allogeneic stem cell transplantation.

Brief summary: The goal of this study is to calculate pharmacokinetic parameters and to evaluate the trough levels of posaconazole reached in patients with different stages of mucositis, due to chemotherapy and total body irradiation.


Eligibility criteria: Inclusion Criteria:

* Patients receiving allogeneic stem cell transplantation - Treated with prophylactic posaconazole: oral suspension (200mg three times daily) or tablet (300mg once daily) to prevent invasive fungal infections

Exclusion Criteria:

* Gastroparesis
* Vomiting or diarrhea within 2 hours after intake of posaconazole
* Concomitant administration of potent inducers of the enzyme UGT1A4: carbamazepine,phenytoin, phenobarbital, rifabutin, rifampicin,...
* Age under 18 years

Primary outcomes:
measure: Posaconazole plasma levels and area under the curve in patients with different stages of mucositis
timeFrame: Day 0 (day of transplantation), day +7, day +14
Secondary outcomes:
Other outcomes:
Locations:
city: Leuven
country: Belgium
facility: University Hospitals Leuven
state: Vlaams-Brabant
Study officials:
affiliation: Catholic University of Leuven, Faculty of Pharmacy, division Hospital Pharmacy
name: Kim Vanstraelen, R.Ph.
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT04651062: Detection of Adenomas in Screening Colonoscopy
Official title: Detection of Adenomas in Screening Colonoscopy - Endocuff Study
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Adenoma Colon
Keywords: adenoma detection rate
screening colonoscopy
Lead sponsor: Herning Hospital
Sponsor class: OTHER
First posted: 2020-12-03
Enrollment: 1178
Sex: ALL
Minimum age (years): 50
Maximum age (years): 75
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: this is a randomized controlled trial
Primary purpose: DIAGNOSTIC

Brief summary: The Endocuff study aims to show an increase of the number of detected adenomas in screening colonoscopies when a endocuff vision (Arc Medical Design Ldt Leeds England) is used.

Detailed description: Endocuff is a relatively new device which is intended to be attached to the end of the colonoscope. Several minor studies have shown that the use of Endocuff probably increases the number of detected polyps in colonoscopy. Endocuff is made of soft plastic and has been designed to give an optimal view of the entire colon. It gently averts and flattens folds in order to see small polyps "hiding" in the space behind colonic folds.

The purpose of this study is to investigate into the effect of the Endocuff in screening colonoscopy compared with screening colonoscopy performed without Endocuff. The device has been used during several years yet an effect on the number of polyps detected during screenings colonoscopy has not been shown. This studies main hypothesis is that the use of Endocuff in screenings colonoscopy will increase the adenoma detection rate in these patients, with a potential to reduce interval cancer.

This study is a randomized controlled trial with 900 patients.

Eligibility criteria: Inclusion Criteria:

* all Citizens participating in the national bowel screening program

Exclusion Criteria:

* persons who are disabled and who do not understand the Danish language
* persons treated with Marcoumar, Marevan, Eliquis, Pradaxa e.g. and who are not eligible to polyp resection
* persons who due to diseases of the eyes or Heart are not allowed to receive Buscopan.
* persons with active colitis/diverticulitis, colon stenosis e.g. due to cancer, where a complete colonoscopy is not possible to achieve

Primary outcomes:
measure: adenoma
timeFrame: 2 weeks
Secondary outcomes:
measure: cecal intubation rate
timeFrame: up to 2 hours
measure: cecal intubation time
timeFrame: up to 2 hours
measure: withdrawal time
timeFrame: up to 60 minutes
measure: adenoma size
timeFrame: up to 4 weeks
measure: adenoma site
timeFrame: up to 4 weeks
Other outcomes:
Locations:
city: Herning
country: Denmark
facility: Kirurgisk Afdeling
state: Midtjylland
Study officials:
References:
citation: Jaensch C, Jepsen MH, Christiansen DH, Madsen AH, Madsen MR. Adenoma and serrated lesion detection with distal attachment in screening colonoscopy: a randomized controlled trial. Surg Endosc. 2022 Sep;36(9):1-9. doi: 10.1007/s00464-022-09049-5. Epub 2022 Feb 9.
Clinical trial NCT01551862: Complications in Lower Body Lifts
Official title: Prospective Study on Complications Following a Lower Body Lift After Massive Weight Loss
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Surplus Skin After Massive Weight Loss
Keywords: lower body lift
body contouring surgery
massive weight loss
Lead sponsor: Medical University of Vienna
Sponsor class: OTHER
First posted: 2012-03-13
Enrollment: 50
Sex: ALL
Minimum age (years): 18
Maximum age (years): 64
Standard ages: ADULT
Accepts healthy volunteers: yes
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients which are referred to Department of Plastic Surgery for body contouring surgery

Brief summary: A prospective study on 50 consecutive patients who are going to have a lower body lift procedure is performed. Measures include comorbidities and complications. Risk factors assessed including patient age, gender, highest lifetime body mass index (BMI) (BMI max), current BMI, excess weight loss (EWL), type of weight loss and nicotine consumption.


Eligibility criteria: Inclusion Criteria:

* after massive weight loss
* age \> 18 years and \< 65 years
* excess weight loss \> 66%
* current body mass index \< 35
* stable weight after weight loss for at least 12 months

Exclusion Criteria:

* insulin dependent diabetes mellitus

Primary outcomes:
measure: Complications
timeFrame: 6 months
Secondary outcomes:
Other outcomes:
Locations:
city: Vienna
country: Austria
facility: Medical University of Vienna, Dept. of Plastic Surgery
Study officials:
affiliation: Medical University of Vienna
name: Hugo B Kitzinger, MD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Kitzinger HB, Cakl T, Wenger R, Hacker S, Aszmann OC, Karle B. Prospective study on complications following a lower body lift after massive weight loss. J Plast Reconstr Aesthet Surg. 2013 Feb;66(2):231-8. doi: 10.1016/j.bjps.2012.09.006. Epub 2012 Oct 4.
Clinical trial NCT00593762: ASA- and Clopidogrel-Responsiveness in Patients With Peripheral Arterial Occlusive Disease and Interventional Procedures
Official title: Investigation of Laboratory Resistance to Aspirin and Clopidogrel and Its Clinical Relevance in Patients With Peripheral Arterial Occlusive Disease Requiring Interventional Procedures
Study type: OBSERVATIONAL
Overall status: SUSPENDED
Conditions: Peripheral Arterial Occlusive Disease
Keywords: Peripheral arterial occlusive disease
Aspirin
Clopidogrel
Resistance
Catheter interventional procedure
ASA and clopidogrel resistance
Lead sponsor: Johann Wolfgang Goethe University Hospital
Sponsor class: OTHER
First posted: 2008-01-15
Enrollment: 200
Sex: ALL
Minimum age (years): 18
Maximum age (years): 85
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: patients with peripheral arterial occlusive disease (PAOD) requiring a catheter interventional procedure

Brief summary: The purpose of the study is to determine the response to aspirin (ASA) and Clopidogrel in patients with peripheral arterial occlusive disease (PAOD) requiring interventional procedures and to investigate if patients with "resistance" to ASA or Clopidogrel have an unfavourable outcome during long-term follow-up


Eligibility criteria: Inclusion Criteria:

* PAOD patients
* Age 18-85 years
* Need for a catheter interventional procedure
* Antithrombotic therapy with aspirin or clopidogrel

Exclusion Criteria:

* Comedication additionally compromising platelet function
* Known bleeding disorder
* Life expectancy \< 6 months

Primary outcomes:
measure: Need for peripheral arterial revascularisation
timeFrame: 1, 6, 12 and 24 months
Secondary outcomes:
measure: Cardiovascular events (death, myocardial infarction, stroke, ACS, PCI)
timeFrame: 1, 6, 12 and 24 months
Other outcomes:
Locations:
city: Frankfurt/Main
country: Germany
facility: Division of Vascular Medicine, Department of Internal Medicine, J.W.Goethe University Hospital
state: Hessen
Study officials:
affiliation: Division of Vascular Medicine, Department of Internal Medicine, J.W. Goethe University Hospital Frankfurt
name: Birgit Linnemann, MD
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT04194762: PARK-FIT. Treadmill vs Cycling in Parkinson´s Disease. Definition of the Most Effective Model in Gait Reeducation
Official title: Treadmill vs Cycling in Parkinson´s Disease Rehabilitation. Non-pharmacological, Randomized, Blind Rater, Clinical Trial for the Definition of the Most Effective Model in Gait Reeducation
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Parkinson Disease
Lead sponsor: Puerta de Hierro University Hospital
Sponsor class: OTHER
First posted: 2019-12-11
Enrollment: 48
Sex: ALL
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: non pharmacological, randomised, double arm intervention. Treadmill training vs cycling training in equal intensity of exercise conditions.
Primary purpose: TREATMENT

Brief summary: PARK-FIT Treadmill vs Cycling in Parkinson´s Disease Rehabilitation. Non-pharmacological Clinical Trial for the Definition of the Most Effective Model in Gait Reeducation.

Detailed description: Treadmill vs Cycling in Parkinson´s Disease Rehabilitation. Non-pharmacological Clinical Trial for the Definition of the Most Effective Model in Gait Reeducation.

Eligibility criteria: Inclusion Criteria:

* Patient is diagnosed with idiopathic Parkinson's disease according to criteria from the United Kingdom Parkinson's Disease Society Brain Bank (UK-PDSBB)
* H\&Y less than or equal to 2
* Stable drug treatment in the six weeks prior to the start of training and during the study.
* Signature of informed consent.

Exclusion Criteria:

* Diagnosis of other neuro-degenerative disease
* Cardiovascular disease or other systemic condition that contraindicates the moderate physical exercise
* Need for ambulation support
* Frequent freezing of gait events.
* Mni- Mental State Examination (MMSE) \<26

Primary outcomes:
measure: Changes in step length after treadmill training or cycling.
timeFrame: Ten months
measure: Changes in step length after treadmill training. Discussion of its specificity to Parkinson´s disease
timeFrame: Ten months
Secondary outcomes:
measure: Rating Scale for Gait Evaluation in Parkinson's disease ( RSGE- PD scale )
timeFrame: Ten months
Other outcomes:
measure: Movement Disorders Society- Unified Parkinson´s Disease Rating Scale II. (MDS-UPDRS II)
timeFrame: Ten months
measure: MDS-UPDRS III
timeFrame: Ten months
measure: The 39-item Parkinson´s Disease Questionnaire (PDQ-39)
timeFrame: Ten months
Locations:
city: Majadahonda
country: Spain
facility: Hospital Universitario Puerta de Hierro
state: Madrid
Study officials:
References: